Möchten Sie immer auf dem neuesten Stand bleiben?

BENTONVILLE, Ark., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today...

BENTONVILLE, Ark., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced a further strengthening of its Board of Directors with the appointment of Christopher J....

BENTONVILLE, Ark., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced the appointment of Mark Schaftlein as Chief Executive Officer and member of the Board of...

UMeWorld positions DAGola™ for Q4 revenue growth with U.S. e-commerce launch and China rollout; clinically proven oil taps functional nutrition demand.

PALM BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global diabetic retinopathy market has shown a consistent growth in recent years and is expected to continue...

UMeWorld study shows DAGola oil lowers uric acid, triglycerides, cholesterol, and weight - supporting metabolic health with up to 50% fewer triglycerides.

UMeWorld launches Product Innovation Center, names Chief Scientist, and prepares U.S. rollout of DAGola oil with 80% less triglycerides.

UMeWorld Limited announces its shift to a healthy lifestyle brand, introducing personalized wellness solutions and the WellGenix™ AI-powered app.

A new study published in the Journal of Craniofacial Surgery highlights the superior performance of Planatome blades in surgical procedures.

Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The global insulin delivery devices market size was USD 13.37 billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast...